IL-3 is a novel target to interfere with tumor vasculature

Macrophages as tools and targets in cancer therapy

Frontiers Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies

Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation: Molecular Therapy

Tissue architecture in tumor initiation and progression: Trends in Cancer

JCI Insight - JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8

Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer

Targeting the tumor stroma for cancer therapy, Molecular Cancer

Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline

Emerging new therapeutic antibody derivatives for cancer treatment

The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment, Cancer Cell International

Arginase: An emerging and promising therapeutic target for cancer treatment - ScienceDirect

Frontiers IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment

Frontiers Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor